Variant report
Variant | esv2042972 |
---|---|
Chromosome Location | chr13:98148388-98148896 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:42531904..42532590-chr13:98148609..98149589,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571457749 | chr13:98148400-98148401 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148399277 | chr13:98148407-98148408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116409833 | chr13:98148429-98148430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74105498 | chr13:98148434-98148435 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs536264357 | chr13:98148435-98148436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141638692 | chr13:98148474-98148475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566474584 | chr13:98148499-98148500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150529469 | chr13:98148515-98148516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558151192 | chr13:98148526-98148527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113878847 | chr13:98148546-98148547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139518823 | chr13:98148565-98148566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116193640 | chr13:98148606-98148607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73559986 | chr13:98148608-98148609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74105499 | chr13:98148609-98148610 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs542614835 | chr13:98148646-98148647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189083989 | chr13:98148661-98148662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528467291 | chr13:98148667-98148668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545318175 | chr13:98148692-98148693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565009054 | chr13:98148693-98148694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114197874 | chr13:98148742-98148743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs117033435 | chr13:98148766-98148767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs79238347 | chr13:98148796-98148797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7331217 | chr13:98148852-98148853 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs535514496 | chr13:98148874-98148875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Breast cancer | 21785460 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:98146000-98150400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr13:98147400-98154400 | Weak transcription | Right Atrium | heart |
3 | chr13:98147600-98150600 | Enhancers | Fetal Stomach | stomach |
4 | chr13:98147800-98151200 | Enhancers | HepG2 | liver |
5 | chr13:98148000-98153800 | Weak transcription | Fetal Muscle Leg | muscle |
6 | chr13:98148200-98148400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr13:98148200-98149200 | Enhancers | Fetal Lung | lung |
8 | chr13:98148400-98148800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr13:98148800-98149200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr13:98148800-98149200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr13:98148800-98149200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr13:98148800-98149400 | Enhancers | Fetal Intestine Small | intestine |